Keyphrases
Improved Outcomes
100%
Beta-blockers
100%
Inflammatory Profile
100%
Beta-blockade
100%
Interleukin-6
20%
Interleukin-1β
20%
Heart Disease
20%
Injured Patients
20%
Between-group
13%
Trauma Patients
6%
Randomized Controlled Trial
6%
Evidence Support
6%
Clinical High Risk
6%
Enzyme-linked Immunosorbent Assay (ELISA)
6%
Systolic Blood Pressure
6%
Inflammatory Response
6%
Cytokine Levels
6%
Cardioprotection
6%
Resuscitation
6%
Standard of Care
6%
Associated Complications
6%
Intensive Care Unit
6%
Interleukin-6 Levels
6%
Patients at Risk
6%
Admission Heart Rate
6%
Elective Surgery
6%
β-adrenoceptor Antagonists
6%
Serum interleukin-6
6%
Normality Assumption
6%
Base Deficit
6%
Repeated Measures Analysis of Variance
6%
Within-group Differences
6%
Medicine and Dentistry
Injury
100%
Beta Adrenergic Receptor Blocking Agent
100%
Beta Adrenergic Receptor Blocking
100%
Interleukin 6
26%
Heart Disease
20%
Interleukin 1
20%
Cytokine
13%
Randomized Controlled Trial
6%
Analysis of Variance
6%
Base
6%
Serositis
6%
Systolic Blood Pressure
6%
In Vitro
6%
Resuscitation
6%
Arm
6%
Intensive Care Unit
6%
Heart Protection
6%
Enzyme Linked Immunosorbent Assay
6%
Beta Adrenergic Receptor
6%
Receptor Antagonist
6%
Elective Surgery
6%
Immunology and Microbiology
Interleukin 6
100%
Beta Adrenergic Receptor Blocking
100%
Interleukin 1
75%
Cytokine
50%
Systolic Blood Pressure
25%
Blood Plasma
25%
Inflammation Response
25%
Arm
25%
Enzyme-Linked Immunosorbent Assay
25%
Nursing and Health Professions
Injury
100%
Beta Adrenergic Receptor Blocking
100%
Beta Adrenergic Receptor Blocking Agent
100%
Interleukin 6
26%
Interleukin 1
20%
Heart Disease
20%
Inflammation
6%
Health Care Quality
6%
Base
6%
Analysis of Variance
6%
Heart Protection
6%
Resuscitation
6%
Intensive Care Unit
6%
Elective Surgery
6%
Enzyme Linked Immunosorbent Assay
6%
Beta Adrenergic Receptor
6%
Systolic Blood Pressure
6%
Pharmacology, Toxicology and Pharmaceutical Science
Injury
100%
Beta Adrenergic Receptor Blocking Agent
100%
Interleukin 6
26%
Interleukin 1
20%
Heart Disease
20%
Cytokine
13%
Base
6%
Inflammation
6%
Receptor Antagonist
6%
Enzyme-Linked Immunosorbent Assay
6%
Randomized Controlled Trial
6%
Beta Adrenergic Receptor
6%